KELLY BURROWS: Open Payments
NPI 1518292077 · ODESSA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$989 in 25 payments from 12 companies in 2025. Trend: 2023 $665 · 2024 $713 · 2025 $989
Food & beverage: $989
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $326 |
| Novo Nordisk Inc | 4 | $187 |
| ABBVIE INC. | 1 | $123 |
| Hologic Sales and Service, LLC | 1 | $71 |
| Antares Pharma, Inc. | 3 | $60 |
| Axsome Therapeutics, Inc. | 4 | $48 |
| Lilly USA, LLC | 2 | $48 |
| Inspire Medical Systems, Inc. | 1 | $30 |
| ACADIA Pharmaceuticals Inc | 1 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
Products named: FARXIGA, Ozempic, AIRSUPRA, UBRELVY, APTIMA, XYOSTED, Auvelity, MOUNJARO.
Industry payments across TX — which companies pay providers there.
